Delivery Order SPE2DB20D3103-SPE2DB23FM6U4
Award Date 3/7/23
Potential Completion Date 3/8/23
Potential Value $5.2K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award, valued at $2,983.01, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award is for the delivery of Clindamycin PH 1% Gel 30GM, a pharmaceutical product, to support the DLA Troop Support Medical program. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the...
- This federal contract award is for the delivery of Clindamycin PH 1% Gel, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The $2,024.82 Firm Fixed Price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen's parent company, Cencora, Inc., holds with the DLA Troop...
- This federal contract award is for the delivery of Clindamycin Phosphate 1% Gel, in 30-gram tubes, to the Defense Logistics Agency (DLA). The $1,821.87 Firm Fixed Price Delivery Order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on January 4, 2024. The contract has an ultimate completion date of January 5, 2024 and was not designated with a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,065.08 firm fixed-price delivery order is for the supply of Clindamycin PH 1% Gel 30GM, a pharmaceutical product. The contract has an ultimate completion date of March 31, 2025. There is no set-aside designation, indicating this was an open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite...
- This federal contract award, with ID SPE2DB20D3505|SPE2DB21FU4Q4, is for the delivery of Clindamycin PH 1% Gel, 30 grams, to the Defense Logistics Agency (DLA). The $4,731.86 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract has no set-aside designation, indicating open competition. Amerisourcebergen is a major pharmaceutical distributor that supports federal healthcare programs, particularly within the Department of Defense...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The $1,293.20 Firm Fixed Price Delivery Order is for the provision of clindamycin phosphate 1% gel, with a performance period ending on July 10, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,211.13 delivery order contract is for the supply of 4559304324 - Clindamycin PH 1% Gel 30GM, with a completion date of December 8, 2022. The contract has a firm fixed price pricing type and is not designated as a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
- This federal contract award is for the delivery of Clindamycin Phosphate 1% Gel, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on March 7, 2022, with a ceiling value of $1,091.86. The contract is a Firm Fixed Price Delivery Order, with a completion date of March 8, 2022. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., a for-profit organization that specializes in...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,213.78 Firm Fixed Price Delivery Order is for the supply of Clindamycin Phosphate 1% Gel, a pharmaceutical product, to support military healthcare programs. The contract has an ultimate completion date of December 20, 2023 and was awarded on December 19, 2023 with no set-aside designation. Amerisourcebergen Drug Corp holds a larger $999,999,999...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract valued at $1,348.34 to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of 4,564,327,564 units of Clindamycin Phosphate 1% Lotion in 60 mL containers. This order is under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. The IDC...